English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Diabetes mellitus (DM) frequently affects the nervous system [1]. This holds true both for the peripheral and for the autonomic nervous system [2]. Diabetic polyneuropathy (or distal symmetrical polyneuropathy [DPN] or, simply, peripheral neuropathy) is the most common manifestation of DM in the nervous system [3, 4]. Of the autonomic nervous system, gastrointestinal autonomic neuropathy [5] and cardiovascular autonomic diabetic neuropathy (CAN) are those most widely studied. Importantly, CAN is a recognised harbinger of cardiovascular mortality [6–8].

advances in therapy

Letter to the Editor Regarding: Diabetic Peripheral Neuropathy as a Predictor of Asymptomatic Myocardial Ischemia in Type 2 Diabetes Mellitus: A Cross-Sectional Study